Novartis CEO Steers Drug Maker Back to R&D
WSJ -

Vasant Narasimhan, the 41-year-old chief executive at Novartis AG, is vowing data science and digital technologies will revolutionize the company’s drug-development pipeline.

Loading...

Related Articles